Prestige V + WNV Vaccine
(Flu/Rhino/EWT/WN) Merck

• Multiple antigen combination reduces need for several injections
• Formulated to minimize reactions and maximize protection
• Available in 10-dose vials and 1 mL single-dose prefilled syringes
• Tetanus, WNV, EEE and WEE are core vaccinations recommended by the AAEP vaccine guidelines and are indicated in the immunization program for all horses each year
• Provides 6 months of protection against EIV
• A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), equine herpesvirus types 1 and 4 (EHV-1 and EHV-4), equine influenza virus type H3N8 strains EIV A/eq/Florida/RW/13, EIV A/Equine 2/Kentucky/02 American, EIV A/eq/Richmond/1/07, West Nile virus – flavivirus chimera and tetanus toxoid
• Advanced filtration process through the Antigen Purification System (APS™)
• Exceptional safety profile with the exclusive Havlogen® Adjuvant

Indications

This product has been shown effective for the vaccination of healthy horses 6 months of age or older against Eastern and Western encephalomyelitis (EEE and WEE) viruses, equine influenza virus (EIV), equine herpesvirus type 1 (EHV-1), equine herpesvirus type 4 (EHV-4), tetanus and West Nile Virus. Duration of immunity has been shown at 6 months for EIV. Duration of immunity for Eastern and Western encephalomyelitis viruses, EHV-1, EHV-4, tetanus and West Nile Virus has not been established. For more information regarding safety and efficacy data, go to productdata.aphis.usda.gov.

This product has been shown to be effective against virus shedding of EIV, EHV-1 and EHV-4, and encephalitis and viremia caused by West Nile Virus.